Home LiteratureArticle Details
PMID: 6327539 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Calcium concentration defines two stages in transformation of lymphocytes by Epstein-Barr virus.

International journal of cancer ·Vol. 33 ·No. 5 ·1984-05-15 ·Pages 587-90

Moss DJ, Burrows SR, Parsons PG

Abstract

Lymphocytes from Epstein-Barr virus (EBV) seronegative donors were either stimulated with Protein A or infected with EBV and cultured in growth medium containing a range of calcium levels (700 microM to less than 2 microM available calcium). Three calcium end-points for the proliferation of B lymphocytes were defined: 18 microM for mitogenically-stimulated B cells; 8 microM for a pre-12 h event in EBV transformation and less than 2 microM for a post-12 h event in EBV transformation resembling the end-point for the emergent lymphoblastoid cell line. EBV-infected lymphocytes cultured in calcium-depleted medium expressed the EB virus nuclear antigen and proliferated after addition of calcium chloride. The present study should be useful both in defining the sequence of events in EBV transformation and in studying properties specific to the transformed phenotype.

MeSH Terms
Antigens, Viral/analysis Calcium/physiology Cell Transformation, Viral Egtazic Acid/pharmacology Herpesvirus 4, Human/immunology,pathogenicity Humans Lymphocyte Activation Thymidine/metabolism
Chemicals
Antigens, Viral Egtazic Acid Calcium Thymidine
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Moss D J
Burrows S R
Parsons P G
Article Info
Journal
International journal of cancer
Abbr.
Int J Cancer
ISSN
0020-7136
Published
1984-05-15
Pages
587-90
Language
English
Region
United States
NLM ID
0042124
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com